| BRCA1 |
DNA |
gene mutation |
may cause |
|
chromatin remodeling |
Breast
Neoplasms |
|
mutation in the BRCA1 gene may
cause abnormal chromatin remodeling associated with breast neoplasms
[9], E |
| BRCA1 |
DNA |
gene deletion mutation |
may cause |
increased occurrence of familial
form |
|
Breast
Neoplasms
|
|
deletion mutation in the BRCA1
gene may cause increased occurrence of familial form of breast
neoplasms [15], E; [10], E |
| BRCA1 |
DNA |
gene deletion mutation |
may cause |
|
transcription |
Breast
Neoplasms
|
|
deletion mutation in the BRCA1
gene may cause abnormal transcription associated with breast neoplasms
[12], E |
| BRCA1 |
Protein |
altered protein stability |
may cause |
|
|
Breast
Neoplasms
|
|
abnormal stability of BRCA1 may
cause breast neoplasms [5], E |
| BRCA1 |
DNA |
gene mutation |
may cause |
increased occurrence of familial
form |
|
Breast
Neoplasms
|
|
mutation in the BRCA1 gene may
cause increased occurrence of familial form of breast neoplasms
[3], E |
| BRCA1 |
Protein |
ubiquitin-protein ligase activity
|
may cause |
|
protein polyubiquitination |
Breast
Neoplasms
|
|
absence of the ubiquitin-protein
ligase activity of BRCA1 may cause
decreased protein polyubiquitination associated with breast neoplasms
[7], E |
| BRCA1 |
DNA |
gene mutation |
may cause |
|
protein polyubiquitination |
Breast
Neoplasms
|
|
mutation in the BRCA1 gene may
cause decreased protein polyubiquitination associated with breast
neoplasms [7], E |
| BRCA1 |
DNA |
gene mutation |
causes |
increased occurrence of early
onset form |
|
Breast
Neoplasms
|
|
mutation in the BRCA1 gene causes
increased occurrence of early onset form of breast neoplasms
[14], E; [2], E |
| BRCA1 |
DNA |
promoter hypermethylation |
may cause |
non-familial/sporadic |
|
Breast
Neoplasms
|
|
hypermethylation of the BRCA1
promoter may cause non-familial form of breast neoplasms [13], E |
| BRCA1 |
DNA |
gene deletion mutation |
may cause |
|
chromatin remodeling |
Breast
Neoplasms
|
|
deletion mutation in the BRCA1
gene may cause abnormal chromatin remodeling associated with breast
neoplasms [12], E |
| BRCA1 |
DNA |
gene nonsense mutation |
may cause |
increased occurrence of familial
form |
|
Breast
Neoplasms
|
|
nonsense mutation in the BRCA1
gene may cause increased occurrence of familial form of breast
neoplasms [15], E; [10], E |
| BRCA1 |
DNA |
gene missense mutation |
may cause |
increased occurrence of familial
form |
|
Breast
Neoplasms
|
|
missense mutation in the BRCA1
gene may cause increased occurrence of familial form of breast
neoplasms [15], E; [10], E |
| BRCA1 |
DNA |
gene mutation |
may cause |
|
DNA repair |
Breast
Neoplasms
|
|
mutation in the BRCA1 gene may
cause decreased DNA repair associated with breast neoplasms
[4], E |
| BRCA1 |
DNA |
gene insertion mutation |
may cause |
increased occurrence of familial
form |
|
Breast
Neoplasms
|
|
insertion mutation in the BRCA1
gene may cause increased occurrence of familial form of breast
neoplasms [15], E |
| BRCA1 |
Protein |
transcription activator activity
|
may cause |
increased occurrence of familial
form |
|
Breast
Neoplasms
|
|
decreased transcription activator
activity of BRCA1 may cause increased
occurrence of familial form of breast neoplasms [10], E |
| BRCA1 |
DNA |
promoter hypermethylation |
may cause |
|
|
Breast
Neoplasms
|
|
hypermethylation of the BRCA1
promoter may cause breast neoplasms [13], E |
| BRCA1 |
Protein |
decreased folding |
may cause |
|
|
Breast
Neoplasms
|
|
decreased folding of BRCA1 may
cause breast neoplasms [1], E |
| BRCA1 |
DNA |
protein domain missense mutation
|
causes |
|
|
Breast
Neoplasms
|
|
missense mutation in the BRCA1 C
Terminus (BRCT) domain of BRCA1 causes breast neoplasms [1], E |
| BRCA1 |
Protein |
decreased protein stability |
may cause |
|
|
Breast
Neoplasms
|
|
decreased stability of BRCA1 may
cause breast neoplasms [1], E |
| BRCA1 |
DNA |
gene mutation |
may cause |
|
transcription |
Breast
Neoplasms
|
|
mutation in the BRCA1 gene may
cause abnormal transcription associated with breast neoplasms
[8], E |
| BRCA1 |
DNA |
gene mutation |
causes |
familial |
|
Breast
Neoplasms
|
|
mutation in the BRCA1 gene causes
familial form of breast neoplasms [16], E |
| BRCA1 |
DNA |
mutation in PFAM domain |
causes |
|
|
Breast
Neoplasms
|
|
mutation in the BRCA1 C Terminus
(BRCT) domain of BRCA1 causes breast neoplasms [5], E |
| BRCA1 |
DNA |
gene mutation |
causes |
familial |
|
Ovarian
Neoplasms |
|
mutation in the BRCA1 gene causes
familial form of ovarian neoplasms [16], E |
| BRCA1 |
DNA |
gene deletion mutation |
may cause |
increased occurrence of familial
form |
|
Ovarian
Neoplasms |
|
deletion mutation in the BRCA1
gene may cause increased occurrence of familial form of ovarian
neoplasms [10], E |
| BRCA1 |
DNA |
promoter hypermethylation |
may cause |
non-familial/sporadic |
|
Ovarian
Neoplasms |
|
hypermethylation of the BRCA1
promoter may cause non-familial form of ovarian neoplasms [13], E |
| BRCA1 |
DNA |
promoter hypermethylation |
may cause |
|
|
Ovarian
Neoplasms |
|
hypermethylation of the BRCA1
promoter may cause ovarian neoplasms [13], E |
| BRCA1 |
DNA |
gene nonsense mutation |
may cause |
increased occurrence of familial
form |
|
Ovarian
Neoplasms |
|
nonsense mutation in the BRCA1
gene may cause increased occurrence of familial form of ovarian
neoplasms [10], E |
| BRCA1 |
Protein |
transcription activator activity
|
may cause |
increased occurrence of familial
form |
|
Ovarian
Neoplasms |
|
decreased transcription activator
activity of BRCA1 may cause increased
occurrence of familial form of ovarian neoplasms [10], E |
| BRCA1 |
DNA |
gene missense mutation |
may cause |
increased occurrence of familial
form |
|
Ovarian
Neoplasms |
|
missense mutation in the BRCA1
gene may cause increased occurrence of familial form of ovarian
neoplasms [10], E |
| BRCA1 |
Protein |
increased protein expression |
may cause |
|
cell proliferation |
Prostatic
Neoplasms |
|
increased expression of BRCA1
protein may cause increased cell proliferation associated with
prostatic neoplasms [6], E |
| BRCA1 |
Protein |
transcription coactivator activity
|
may cause |
|
cell death |
Prostatic
Neoplasms |
|
increased transcription
coactivator activity of BRCA1 may cause
increased cell death associated with prostatic neoplasms [11], E |